Northern Trust Company of Connecticut’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2013
Q4
$31.7M Sell
440,674
-19,458
-4% -$1.35M 0.2% 108
2013
Q3
$31.6M Buy
460,132
+63,935
+16% +$4.23M 0.2% 104
2013
Q2
$25.1M Buy
+396,197
New +$25.8M 0.17% 152

Other funds holding NVS

Northern Trust Company of Connecticut's NVS Position: Q4 2013 in Review

Northern Trust Company of Connecticut reduced its Novartis (NVS) stake by 4.2% in Q4 2013, selling an estimated $1.35M and leaving 440,674 shares worth $31.7M. The position accounts for 0.2% of the portfolio, ranked #108.

Northern Trust Company of Connecticut first reported a position in NVS in Q2 2013 and has held it in 3 quarters since. 816 funds tracked by Wall St. Rank hold NVS as of Q4 2013.

  • Northern Trust Company of Connecticut held 440,674 shares of Novartis worth $31.7M as of Q4 2013.
  • Northern Trust Company of Connecticut sold 19,458 Novartis shares in Q4 2013, an estimated $1.35M.
  • Novartis made up 0.2% of Northern Trust Company of Connecticut's portfolio in Q4 2013, its #108 holding.
  • Northern Trust Company of Connecticut first reported a position in Novartis in Q2 2013 and has held it in 3 quarters since.
  • 816 funds tracked by Wall St. Rank held Novartis as of Q4 2013.

Based on Northern Trust Company of Connecticut's 13F filing for Q4 2013, filed 12 Feb 2014.